Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS San Raffaele160 AstraZeneca137 Merck Sharp & Dohme LLC98 Hoffmann-La Roche80 Novartis Pharmaceuticals73
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Milan

2846 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
European Institute of Oncology
Phase 3
95
Milan
2024-12-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
80
Milan
2024-12-01
Active, closed
Pharvaris Netherlands B.V.
Phase 3
81
Milan, Padova
2024-12-01
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Alessandria, Bologna, Busto Arsizio, Milan, Roma
2024-11-27
Recruiting
BeOne Medicines
Phase 1/2
80
Bologna, Milan, Naples, Rozzano, Verona
2024-11-27
Recruiting
Cognitive Evaluation of Patients With Eating Disorders
NCT07478510ARFID, Anorexia Nervosa, Bulimia Nervosa, Cognitive Flexibility
Istituti Clinici Scientifici Maugeri SpA
Observational
84
Pavia, Milan
2024-11-26
Active, closed
AbbVie
Observational
1,314
Milan, Naples, Turin, Rome, Ancona, Bari, Catanzaro, Pavia
2024-11-26
Recruiting
Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.
NCT06701630Neurologically Unimpaired Elderly Participants, Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI), Major Neurocognitive Disorder
Casa di Cura IGEA
Observational
390
Milan
2024-11-26
Recruiting
Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
NCT06737107Early Stage Lung Cancer (I and II), Non-Small Cell Lung Cancer
Scientific Institute San Raffaele
Observational
472
Rozzano, Milan, Rome
2024-11-26
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
NCT07401615Non Small Cell Lung Cancer, Pulmonary Stereotactic Radiotherapy
Istituto Clinico Humanitas
Observational
150
Bergamo, Bologna, Catania, Milan, Rozzano, Naples, Roma, Venezia
2024-11-25
Active, closed
DJO UK Ltd
Not applicable
64
Caserta, Milan, Roma
2024-11-23
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2
31
Milan
2024-11-22
Recruiting
IRCCS San Raffaele
Not applicable
50
Milan
2024-11-21
Recruiting
UCB Biopharma SRL
Phase 3
450
Brescia, Genova, Milan, Padova, Pisa, Roma, Rozzano
2024-11-21
Recruiting
Catholic University of the Sacred Heart
Not applicable
30
Milan
2024-11-20
Active, closed
Gilead Sciences
Phase 2/3
75
Milan, Roma
2024-11-20
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
NCT06690775Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Endometrioid Ovarian Cancer
DrugsTORL-1-23·Pegfilgrastim
TORL Biotherapeutics, LLC
Phase 2
230
Bari, Milan, Prato, Rome
2024-11-20
By invitation
UCB Biopharma SRL
Phase 3
8
Milan
2024-11-19
Active, closed
Daiichi Sankyo
Phase 3
700
Bari, Brescia, Meldola, Milan, Novara, Palermo, Roma, Rome
2024-11-19
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
100
Bari, Florence, Genova, Milan, Salerno
2024-11-18
Recruiting
Guna S.p.a
Not applicable
42
Milan
2024-11-18
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Bologna, Padova, Florence, Catania, Milan, Turin
2024-11-15
Active, closed
Pfizer
Phase 3
200
L’Aquila, Bari, Milan, Rome, Brescia, Latina, Pavia, Roma
2024-11-15
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
110
Bari, Milan
2024-11-14
By invitation
Mario Stirpe
Observational
400
Milan, Novara, Rome, Sassari, Genoa
2024-11-14
Recruiting
Functional Capacity in Anderson-Fabry Disease Patients
NCT06884358Anderson-Fabry Disease
IRCCS Policlinico S. Donato
Observational
100
Brescia, Milan, San Donato Milanese, Monza, Turin
2024-11-13
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Bologna, Foggia, Milan, Modena, Palermo, Rome, Rozzano, Torino
2024-11-12
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Florence, Genoa, Milan, Pavia, Rome, Verona
2024-11-11
Recruiting
argenx
Phase 2
81
Florence, Milan, Modena, Naples, Roma, Rozzano
2024-11-11
Active, closed
GlaxoSmithKline
Phase 2
283
Bergamo, Florence, Milan, Naples, Padova, Pisa, Roma
2024-11-11
Recruiting
Janssen Research & Development, LLC
Phase 3
39
Milan, Rome
2024-11-11
Recruiting
IRCCS San Raffaele
Observational
530
Catanzaro, Milan
2024-11-07
Active, closed
Amgen
Phase 2
409
Bari, Bologna, Chieti, Milan
2024-11-07
Recruiting
Study of IMC-P115C in Advanced PRAME-Positive Cancers
NCT07156136PRAME Positive, Cancer, HLA-A*02:01-positive
Immunocore Ltd
Phase 1
140
Milan, Naples
2024-11-07
Recruiting
CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation
NCT06774365Heart Transplantation, Rejection Heart Transplant, HLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
683
Bari, Bologna, Milan, Naples
2024-11-07
Active, closed
Abbott Medical - VERITAS Study
NCT06707688Atrial Fibrillation (AF), Stoke
Abbott Medical Devices
Not applicable
458
Milan
2024-11-07
Active, closed
Sanofi
Phase 2
556
Torette, Monserrato, Cona, Genoa, Milan, Rozzano, Rome, Bergamo
2024-11-07
Recruiting
PIK3CA Mutational Status Assessment
NCT06706570Breast Cancer Metastatic
European Institute of Oncology
Observational
100
Milan
2024-11-06
Active, closed
Home Rehabilitation as Continuity of Care in MS
NCT06699095Multiple Sclerosis
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Not applicable
20
Milan
2024-11-06
Recruiting
University College Cork
Observational
300
Feltre, Bari, Milan, Naples, Pavia
2024-11-04
Recruiting
IRCCS Fondazione Stella Maris
Not applicable
194
Genova, Bosisio Parini, Milan, Pavia, Calambrone, Salerno
2024-11-04
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Milan, Roma
2024-11-03
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
100
Ancona, Bergamo, Bologna, Brescia, Candiolo, Florence, Milan, Naples
2024-11-01
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
200
Chieti, Milan, Messina, Roma
2024-11-01
Recruiting
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
NCT06790264Breast Cancer Invasive, Node Positive Breast Cancer
European Institute of Oncology
Not applicable
92
Milan
2024-11-01
Not yet open
High Definition Profiling of Ovarian Cancer Ascites
NCT06553742Ovarian Cancer, High Grade Ovarian Serous Adenocarcinoma, Ascites
European Institute of Oncology
Observational
50
Milan
2024-11
Not yet open
High Versus Lower Intensity Surveillance Following Resection of Retroperitoneal Sarcoma
NCT06480396Sarcoma,Soft Tissue, Sarcoma Retroperitoneal
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 3
584
Milan
2024-11
Recruiting
Istituto Ortopedico Rizzoli
Observational
1,000
Bologna, Genova, Milan, Pavia, Roma, Rozzano
2024-10-31
Recruiting
Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities
NCT06380530Musculoskeletal Deformity, Musculoskeletal Abnormalities, Musculoskeletal Disorder
Istituto Ortopedico Rizzoli
Not applicable
100
Bologna, Rozzano, Genova, Milan, Pavia, Roma
2024-10-31
Recruiting
Abivax S.A.
Phase 2
212
Bologna, Catanzaro, Milan, Negrar, Pavia, Roma, Rozzano, San Giovanni Rotondo
2024-10-30
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
241
Milan, Aviano, Bergamo, Bologna, Brescia, Cagliari, Cuneo, Florence
2024-10-30
Not yet open
Mandibular Advancement Planning Based on Clinical Overjet
NCT06653075Overjet, Class II Division 1 Malocclusion
IRCCS Ospedale San Raffaele
Not applicable
50
Milan
2024-10-30
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Rome, Milan, Florence, Ancona
2024-10-30
Recruiting
The Orienting Study
NCT07504146CPPD - Calcium Pyrophosphate Deposition Disease, Gout
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
450
Milan
2024-10-30
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
51
Milan
2024-10-29
Recruiting
IRCCS Eugenio Medea
Not applicable
40
Bosisio Parini, Calambrone, Milan, Pavia, Roma, Salerno
2024-10-29
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Ancona, Bergamo, Brescia, Genova, Milan, Pescara, Perugia, Pisa
2024-10-29
Active, closed
Eli Lilly and Company
Phase 2
45
Milan, Naples, Rome
2024-10-25
Recruiting
European Institute of Oncology
Observational
60
Milan
2024-10-24
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
400
Monserrato, Milan, Naples
2024-10-24
Recruiting
TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial
NCT06685744Parkinson Disease, Multiple Sclerosis, Neurologic Diseases, General
Fondazione Don Carlo Gnocchi ETS
Not applicable
300
Bari, Genova, Lecco, Milan, Modena, Pavia
2024-10-23
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
56
Candiolo, Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Milan
2024-10-23
Recruiting
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NCT06681012Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl
Not applicable
330
Bologna, Milan, Naples, Padova, Pavia, Pisa, Roma
2024-10-22
Recruiting
Pfizer
Phase 3
900
Meldola, Rome, Rozzano, Cremona, Milan, Naples, Terni, Trento
2024-10-22
Recruiting
The Sagittarius Trial
NCT06490536Colon Cancer Stage II, Colon Cancer Stage III
DrugsFolinic acid·Panitumumab·Pertuzumab·Temozolomide
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3
700
Biella, Brescia, Genova, Milan, Rozzano, Novara, Parma, Perugia
2024-10-22
Active, closed
Pfizer
Phase 3
600
Meldola, Rome, Milan
2024-10-21
Recruiting
Christian Cipriani
Not applicable
47
Acerenza, Milan, Roma, Salerno, Sant'Angelo dei Lombardi, Tricarico
2024-10-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
680
Catanzaro, Ravenna, Rome, Milan, Naples, Padova, Verona
2024-10-21
Recruiting
EpigenOMic Determinants of the Neuroendocrine Phenotype As Biomarkers for Neuroendocrine Neoplasms
NCT06785597Mixed Neuroendocrine-Non Neuroendocrine Neoplasm, Neuroendocrine Neoplasm
European Institute of Oncology
Observational
130
Milan
2024-10-21
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2
300
Milan
2024-10-18
Recruiting
argenx
Phase 3
69
Bassano del Grappa, Florence, Milan, Novara, Ravenna, Reggio Emilia, Torino, Trieste
2024-10-18
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Meldola, Milan, Padova, Pisa, Rozzano
2024-10-18
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Milan, Modena, Pisa, Torino
2024-10-17
Active, closed
Revolution Medicines, Inc.
Phase 3
500
Milan, Padova, Pisa
2024-10-16
Active, closed
Uniquity One (UNI)
Phase 2
184
Milan, Campobasso, Padova, Roma, Pieve Emanuele, Verona
2024-10-16
Recruiting
UCB Biopharma SRL
Phase 2/3
8
Milan
2024-10-16
Recruiting
Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination
NCT06635525Chronic Kidney Disease Requiring Chronic Dialysis, Vaccine Response
DrugInfluenza vaccination
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
146
Milan
2024-10-16
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer, Triple Negative Breast Cancer
Novartis Pharmaceuticals
Phase 1
162
Milan, Reggio Emilia
2024-10-15
Recruiting
Study of ATX-01 in Participants With DM1
NCT06300307Myotonic Dystrophy 1
ARTHEx Biotech S.L.
Phase 1/2
56
Milan, Rome
2024-10-15
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Alessandria, Bergamo, Bologna, Catania, Florence, Milan, Monza, Naples
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Bologna, Foggia, Milan, Modena, Novara, Palermo, Rome, Rozzano
2024-10-14
Active, closed
Ipsen
Observational
424
Bergamo, Catania, Florence, Milan, Novara, Roma
2024-10-14
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Bologna, Brescia, Lecco, Milan, Monserrato, Padova, Pisa, Reggio Emilia
2024-10-11
Recruiting
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT06446882HER2-positive Breast Cancer, Early-stage Breast Cancer
Fundacio Clinic Barcelona
Not applicable
304
Milan, Padova
2024-10-11
Active, closed
Incyte Corporation
Phase 2
130
Bergamo, Bologna, Milan, Rome, Rozzano, Torino
2024-10-11
Recruiting
Boehringer Ingelheim
Phase 2
588
Ancona, Aviano (PN), Meldola (FC), Milan, Naples, Rome
2024-10-11
Active, closed
Incyte Corporation
Phase 3
349
Catania, Chieti, L’Aquila, Milan, Naples, Perugia, Pisa, Rome
2024-10-10
Active, closed
Eli Lilly and Company
Phase 2
143
Bologna, Brescia, Fano, Florence, Gazzi - Messina, Milan, Modena, Monserrato
2024-10-10
Recruiting
Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.
NCT06933212Cerebral Amyloid Angiopathy, CAA - Cerebral Amyloid Angiopathy
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
86
Milan
2024-10-10
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Rome, Candiolo, Palermo, Bologna, Milan
2024-10-09
Recruiting
Novartis Pharmaceuticals
Phase 2
200
Ancona, Milan, Rozzano, Modena, Palermo, Pavia, Roma, Verona
2024-10-09
Recruiting
The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients
NCT06503016Hypotension, Consciousness, Level Altered, Airway Disease, Respiratory Failure
Università Vita-Salute San Raffaele
Phase 3
400
Milan
2024-10-08
By invitation
UCB Biopharma SRL
Phase 3
12
Bologna, Milan, Naples
2024-10-08
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Bari, Ravenna, Monza, Milan, Naples, Rome, Peschiera del Garda, Bergamo
2024-10-07
Recruiting
Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy
NCT06730464Dilated Cardiomyopathy, Arrhythmogenic Cardiomyopathy, Ventricular Arrhythmia, Hypertrophic Cardiomyopathies
Centro Medico Teknon
Observational
500
Milan
2024-10-07
Recruiting
AbbVie
Phase 2
488
Milan, Pavia, Roma
2024-10-07
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bari, Bologna, Genova, Milan, Padova
2024-10-05
Recruiting
AstraZeneca
Phase 3
744
Bari, Milan, Misterbianco, Monza, Naples, Orbassano, Padova, Parma
2024-10-04
Recruiting
Abiomed Impella RT-DAQ - Observational Study
NCT06308055Cardiogenic Shock
Abiomed Inc.
Observational
125
Milan
2024-10-04
Recruiting
Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Phase 1
256
Bologna, Milan
2024-10-03
Recruiting
Primary Cardiac Lymphoma: Italian Multicenter Experience
NCT05819528Primary Cardiac Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
43
Bergamo, Brescia, Ferrara, Milan, Perugia, Pisa, Roma, Sassari
2024-10-02
Recruiting
EVOLVING AZIMUTH IN MUSA CONTEXT
NCT07022067Heart Failure, Blood Pressure, Weight Change, Telemonitoring
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
184
Milan
2024-10-02
Recruiting
COMparative Performance of General Purpose Models
NCT06584097Neurosurgical Patients
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
42
Milan
2024-10-02
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Bologna, Catania, Milan, Padova, Roma, Salerno
2024-10-02
Recruiting
Mario Negri Institute for Pharmacological Research
Observational
300,000
Milan, Catania, Orbassano, Pozzuoli, Torino, Vercelli
2024-10-01
Recruiting
Istituto Auxologico Italiano
Not applicable
206
Milan
2024-10-01
By invitation
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
70
Milan
2024-10-01
Recruiting
Scientific Institute San Raffaele
Not applicable
2,840
Milan
2024-10-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
650
Milan
2024-10-01
Recruiting
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
NCT06569602Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases
Edwards Lifesciences
Observational
500
Milan
2024-10-01
Not yet open
Chemoreflex Sensitivity in HFpEF
NCT06309537Heart Failure With Preserved Ejection Fraction
Istituto Auxologico Italiano
Observational
60
Milan
2024-10
Not yet open
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
700
Milan, Rome
2024-10
Recruiting
Scientific Institute San Raffaele
Observational
140
Rozzano, Milan, Rome
2024-09-30
Recruiting
Scientific Institute San Raffaele
Observational
386
Rozzano, Milan
2024-09-30
By invitation
The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease
NCT06652776COPD, COPD Exacerbation Acute, Comorbid Chronic Lung Disease on Heart Failure, Mortality
University of Milan
Observational
10,000
Milan
2024-09-30
Active, closed
Hannover Medical School
Not applicable
20
Milan
2024-09-30
Recruiting
GlaxoSmithKline
Phase 1
845
Milan, Naples, Roma, Verona
2024-09-30
Recruiting
GlaxoSmithKline
Phase 2
393
Bergamo, Bologna, Messina, Milan, Padova, Roma
2024-09-27
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 1/2
73
Milan
2024-09-26
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Salerno, Rome, Brescia, Milan, Ponderano (Biella), Roma
2024-09-26
Active, closed
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
210
Milan
2024-09-25
Active, closed
Merus B.V.
Phase 3
699
Ancona, Brescia, Cagliari, Meldola, Milan, Naples, Rome, Rozzano
2024-09-25
Active, closed
argenx
Phase 1
15
Milan
2024-09-24
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
160
Meldola, Milan, Pisa
2024-09-20
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Ferrara, Milan, Naples, Roma
2024-09-19
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Cuneo, Ferrara, Milan, Naples, Novara, Pisa, Rome, Taormina
2024-09-18
Active, closed
argenx
Phase 3
141
Bergamo, Bologna, Milan, Naples, Roma
2024-09-18
Recruiting
AstraZeneca
Phase 1/2
174
Bologna, Milan
2024-09-18
Active, closed
Amgen
Phase 1
49
Alessandria, Milan, Rozzano (MI), Verona
2024-09-17
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Ferrara, Genova, Milan, Pisa, Roma, Torino, Verona
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 4
500
Florence, Milan, Roma, Trieste, Verona
2024-09-17
Active, closed
GlaxoSmithKline
Phase 2
153
Genova, Milan, Naples, Roma, Sassari
2024-09-17
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
NCT06866782Prostate Cancer, Advanced Prostate Cancer, Metastatic Prostate Cancer (mPC)
Fundacio Puigvert
Observational
600
Bologna, Florence, Milan
2024-09-17
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Meldola, Genoa, Milan, Alessandria, Ascoli Piceno, Pavia, Ravenna
2024-09-16
Recruiting
Advanced Imaging Holistic Omics Biobank
NCT06523270Oncologic Disorders, Neurologic Disorder, Pulmonary Disease, Cardiovascular Diseases
IRCCS San Raffaele
Observational
50,000
Milan
2024-09-15
Active, closed
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
NCT06431373Uveitis, Posterior, Uveitis, Intermediate, Uveitis
Priovant Therapeutics, Inc.
Phase 3
371
Perugia, Milan, Reggio Emilia, Roma
2024-09-11
Recruiting
GlaxoSmithKline
Phase 3
440
Ancona, Milan, Modena, Naples, Padova, Palermo, Pavia, Pisa
2024-09-11
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
130
Florence, Milan, Rozzano, Vicenza
2024-09-11
Active, closed
GCP-Service International West GmbH
Phase 2
41
Ancona, Bari, Candiolo, Florence, Milan, Reggio Calabria
2024-09-10
Recruiting
Blood Extracellular Vesicles as Predictive Recovery Biomarker After Stroke and Brain Injury
NCT06871800Stroke, Vascular Severe Brain Injury, Rehabilitation
Fondazione Don Carlo Gnocchi ETS
Observational
60
Florence, Milan, Torino
2024-09-09
Active, closed
Amgen
Phase 3
315
Cona, Cremona, Milan, Naples, Ravenna, Sondrio, Terni
2024-09-09
Recruiting
European Institute of Oncology
Not applicable
82
Milan
2024-09-06
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
NCT06476808High-grade Serous Ovarian Carcinoma (HGSOC), Uterine Serous Carcinoma (USC), Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 1
240
Milan
2024-09-06
Recruiting
SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective
NCT06373601Coronary Artery Disease, Stenosis Coronary, Coronary Artery Lesion, Percutaneous Coronary Intervention
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS
Not applicable
140
Mercogliano, Bergamo, Brescia, Ferrara, Milan, Rozzano, Naples, Orbassano
2024-09-05
Recruiting
Angela Toss
Observational
100
Genova, Milan, Modena, Padova, Roma
2024-09-05
Active, closed
Novartis Pharmaceuticals
Phase 2
179
Alessandria, Ancona, Genova, Milan, Rozzano, Pescara, Pisa, Pavia
2024-09-04
Recruiting
AbbVie
Phase 2
590
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Rome, Turin, Negrar, Catanzaro
2024-09-04
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Foggia, San Giovanni Rotondo, Rozzano, Torino, Bologna, Catania, Messina, Milan
2024-09-04
By invitation
Giovanni Di Perri
Observational
200
Genova, Milan, Torino, Bari, Catania, Naples, Padova, Roma
2024-09-02
Recruiting
European Institute of Oncology
Not applicable
60
Milan
2024-09-01
Recruiting
Arch Size Study for Anatomical Variations
NCT06235619Aortic Arch, Aneurysm, Dissection, Aortic
IRCCS San Raffaele
Observational
500
Milan
2024-09-01
Recruiting
Speech and Language Interventions for Italian People With PPA
NCT06739967Primary Progressive Aphasia(PPA)
Istituti Clinici Scientifici Maugeri SpA
Observational
30
Bari, Milan
2024-09-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
192
Milan
2024-09-01
Recruiting
IRCCS San Raffaele
Observational
123
Milan
2024-09-01
Recruiting
Fondazione Don Carlo Gnocchi ETS
Observational
2,000
Milan
2024-08-31
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Not applicable
100
Milan
2024-08-31
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
48
Campania, Milan, Pisa, Rome, Verona
2024-08-31
Recruiting
IRCCS San Raffaele
Not applicable
30
Milan
2024-08-31
Recruiting
Ospedale San Raffaele
Observational
250
Milan
2024-08-30
Active, closed
Sanofi
Phase 2
229
Milan, Padua, Pisa
2024-08-29
Active, closed
Microbiotica Ltd
Phase 1
41
Milan, Naples, Rozzano
2024-08-28
Recruiting
Bayer
Phase 3
555
Avellino, Aviano, Bologna, Florence, Lecce, Meldola, Milan, Orbassano
2024-08-28
Active, closed
Gilead Sciences
Phase 3
640
Aviano, Florence, Lecco, Meldola, Milan, Padova, Pisa, Roma
2024-08-28
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Milan, Roma, Rome
2024-08-28
Active, closed
AstraZeneca
Phase 2
194
Genoa, Meldola, Milan, Naples, Orbassano, Perugia, Rozzano, Udine
2024-08-27
Recruiting
Observational Study of Venus P-Valve
NCT05835349Right Ventricular Outflow Tract Dysfunction
Venus MedTech (HangZhou) Inc.
Observational
200
Rome, Milan
2024-08-26
Active, closed
Kite, A Gilead Company
Phase 3
452
Milan, Bologna, Roma, Torino
2024-08-23
Recruiting
Sanofi
Phase 3
160
Milan, Rozzano, Padua, Bologna
2024-08-21
Active, closed
Diakonhjemmet Hospital
Phase 4
387
Milan
2024-08-20
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Meldola, Milan, Torino
2024-08-19
By invitation
Pericardial Fluid Analysis in Recurrent Pericarditis
NCT06293924Acute Pericarditis, Pericardial Effusion, Pericardial Disease, Pericardial Fluid Exudate
ASST Fatebenefratelli Sacco
Observational
432
Milan
2024-08-18
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
DrugZilovertamab vedotin
Merck Sharp & Dohme LLC
Phase 1/2
90
Milan, Rome, Torino
2024-08-16
Recruiting
MiCrobiota-gut-brain Axis in Resistant Epilepsy
NCT07010445Gut Microbiota, Epilepsy, Drug-Resistant Epilepsy
Niguarda Hospital
Not applicable
120
Milan
2024-08-16
Recruiting
Jazz Pharmaceuticals
Phase 3
550
Aviano, Bergamo, Bologna, Milan, Modena, Monza, Padova, Pavia
2024-08-13
Recruiting
AstraZeneca
Phase 3
620
Florence, Milan, Naples, Padova, Roma, Rozzano, Tricase
2024-08-12
Recruiting
AbbVie
Phase 3
110
San Giovanni Rotondo, Rome, Messina, Milan
2024-08-08
Active, closed
Incyte Corporation
Phase 1
37
Bologna, Florence, Milan
2024-08-08
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Bologna, Florence, Milan, Roma, Rome, Udine
2024-08-07
Recruiting
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms, Esophageal Cancer
DrugsPatritumab deruxtecan·Ramucirumab·Sacituzumab tirumotecan·Paclitaxel
Merck Sharp & Dohme LLC
Phase 1/2
210
Meldola, Milan, Pisa
2024-08-07
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
San Giovanni Rotondo, Milan, Roma
2024-08-07
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
102
Aviano, Meldola, Milan, Naples, Perugia, Roma, Rozzano
2024-08-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
Rome, Milan, Turin, Catania
2024-08-05
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
50
Milan
2024-08-01
Recruiting
University of Turin, Italy
Phase 3
420
Rozzano, Orbassano, Milan
2024-08-01
Recruiting
AstraZeneca
Phase 3
788
Bergamo, Bologna, Milan, Modena, Naples, Padova, Reggio Emilia, Rome
2024-08-01
Active, closed
Fidia Farmaceutici s.p.a.
Not applicable
156
Bologna, Florence, Padova, Pavia, Roma, Torino, Milan
2024-08-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Bologna, Genova, Milan, Mirano, Pavia, Reggio Emilia, Terni
2024-07-31
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Bologna, Florence, Genova, Milan, Palermo, Roma, Orbassano
2024-07-31
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-07-30
Active, closed
Annexon, Inc.
Phase 3
659
Florence, Milan, Roma, Rome
2024-07-30
Recruiting
ARCAGY/ GINECO GROUP
Phase 3
250
Alessandria, Bologna, Florence, Lecco, Milan, Venice
2024-07-30
Active, closed
International SBMA Project (KDA)
NCT07443449SBMA, Spinal and Bulbar Muscular Atrophy (SBMA)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
700
Milan
2024-07-29
Active, closed
Università Vita-Salute San Raffaele
Not applicable
100
Milan, Verona
2024-07-29
Recruiting
Niguarda Hospital
Observational
26
Milan
2024-07-25
Recruiting
Marco Emilio Bianchi
Observational
70
Naples, Milan
2024-07-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
686
Bologna, Milan, Monza, Rozzano, Turin, Brescia, Catania, Naples
2024-07-24
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
16
Monserrato, Meldola, San Giovanni Rotondo, Tricase, Milan, Padova, Pisa, Prato
2024-07-23
Active, closed
MedSIR
Phase 2
165
Bergamo, Milan, Novara, Roma
2024-07-22
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Monserrato, Candiolo, Genova, Milan, Naples, Padova, Pisa, Roma
2024-07-19
Active, closed
Celldex Therapeutics
Phase 3
976
Genova, Milan, Padova, Rozzano, Salerno, San Donato Milanese, Torino
2024-07-19
Recruiting
Digital diagnoSis of Cardiac sOUNd in peDiatric Patients [DI-SOUND Study]
NCT07542509Cardiac Disease, Auscultation of Heart, Machine Learning
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Bologna, Milan, Roma, Naples
2024-07-18
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bologna, Brescia, Catanzaro, Milan, Negrar, Padova, Roma, Rozzano
2024-07-18
Recruiting
Bristol-Myers Squibb
Phase 1/2
224
Milan, Padua, Verona
2024-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
38
Milan, Naples
2024-07-17
Recruiting
Amgen
Phase 3
450
Brescia, Castellana Grotte, Florence, Foggia, Genova, Meldola FC, Milan, Naples
2024-07-17
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Naples, Ferrara, Piacenza, Florence, Livorno, Bergamo, Milan, Pesaro
2024-07-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Florence, Alessandria, Bologna, Milan, Pavia, Roma, Varese
2024-07-16
Recruiting
Istituto Auxologico Italiano
Observational
220
Milan
2024-07-15
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Milan, Rozzano, Rome, Messina, Palermo, Pavia, Pisa
2024-07-12
Active, closed
Fidia Farmaceutici s.p.a.
Not applicable
72
Milan, Naples, Roma, Torino
2024-07-12
Active, closed
Celldex Therapeutics
Phase 3
963
Ancona, Mantua, Milan, Naples, Torino, Verona
2024-07-11
Recruiting
Fibrosis Lessens After Metabolic Surgery
NCT06374875Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis
The Cleveland Clinic
Phase 4
120
Milan, Roma
2024-07-11
Recruiting
IRCCS San Raffaele
Observational
1,000
Milan
2024-07-10
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
DrugIvosidenib
Servier Bio-Innovation LLC
Phase 3
136
Bologna, Milan, Orbassano, Padova, Palermo, Prato, Roma
2024-07-09
Recruiting
Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
NCT06495723Peripheral T Cells Lymphoma (PTCL)
Xenothera SAS
Phase 1/2
54
Naples, Bologna, Milan
2024-07-09
Recruiting
University of Bologna
Observational
120
Bologna, Catania, Milan, Padova, Palermo, Rome, Siena, Turin
2024-07-09
Recruiting
AbbVie
Phase 3
40
Florence, Milan, Rome
2024-07-08
Recruiting
GlaxoSmithKline
Phase 1
675
Aviano PN, Milan, Naples, Roma
2024-07-02
Recruiting
Fluorescence Enhanced Stereotactic Surgery (FESS)
NCT07286903High Grade Glioma, High Grade Glioma (III or IV)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
20
Milan
2024-07-01
Active, closed
AstraZeneca
Phase 3
339
Brescia, Cona, Florence, Milan, Naples, Reggio Emilia, Roma, Rome
2024-06-29
Recruiting
Boehringer Ingelheim
Phase 1/2
768
Ancona, Candiolo (TO), Meldola (FC), Milan, Misterbianco (CT), Naples, Rozzano
2024-06-28
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Milan, Perugia
2024-06-28
Active, closed
AbbVie
Phase 3
1,400
Cona, Florence, Rozzano, Naples, Rome, Catania, Milan
2024-06-27
Recruiting
Visual Involvement in Giant Cell Arteritis
NCT06500728Giant Cell Arteritis, Visual Impairment, Central Retinal Artery Occlusion, Anterior Ischemic Optic Neuropathy
ASST Fatebenefratelli Sacco
Observational
762
Milan
2024-06-27
Recruiting
A Registry-study of ELZONRIS in Participants With BPDCN
NCT07785154Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
DrugTagraxofusp
Stemline Therapeutics, Inc.
Observational
80
Alessandria, Bologna, Catania, Cuneo, Ferrara, Florence, Genova, Milan
2024-06-26
Recruiting
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
50
Milan
2024-06-26
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Bergamo, Bologna, Genova, Milan, Pavia, Rome, Treviso
2024-06-25
Recruiting
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
NCT06467383Non-small Cell Lung Cancer, NSCLC, NSCLC, Stage III, NSCLC, Stage I
MSD Italia S.r.l.
Observational
600
San Giovanni Rotondo, Brescia, Campobasso, Catania, Florence, Genova, Messina, Milan
2024-06-25
Active, closed
Merus B.V.
Phase 3
621
Brescia, Cuneo, Milan, Naples, Roma, Rozzano
2024-06-25
Recruiting
How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: a Multicenter Study
NCT06872632Complexity and Multiple Illnesses of Adult Hospitalized Internal Medicine Patient
Società Italiana di Medicina Interna
Observational
2,326
Bari, Bologna, Brescia, Ferrara, Florence, Messina, Milan, Modena
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Naples, Misterbianco, Meldola (FC), Aviano, Rome, Brescia, Milan, Monza
2024-06-24
Recruiting
Cera™ Vascular Plug System Post-Market Clinical Follow-Up
NCT06099015Aneurysm, Endoleak, Pulmonary Arteriovenous Malformation, Portal Hypertension
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
132
Milan, Turin, Varese
2024-06-21
Recruiting
IRCCS San Raffaele
Observational
130
Milan
2024-06-20
Recruiting
Italian iTTP Registry
NCT06376786TTP - Thrombotic Thrombocytopenic Purpura
Fondazione Luigi Villa
Observational
132
Milan
2024-06-20
Recruiting
AstraZeneca
Phase 3
240
Ancona, Bari, Catania, Milan, Padova, Palermo, Pavia, Pisa
2024-06-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Milan, Roma
2024-06-20
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
60
Milan, Roma
2024-06-19
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Bologna, Florence, Milan, Rozzano, Naples, Padova, Rome, Torino
2024-06-19
Recruiting
Istituto Auxologico Italiano
Observational
80
Milan
2024-06-18
Recruiting
Evaluation of the PreCursor-M+® in CIN2
NCT06403618Cervical Intraepithelial Neoplasia Grade 2
European Institute of Oncology
Observational
100
Milan
2024-06-17
By invitation
Bicocca Epidemiological Assessment of Cardiovascular Risk Factors
NCT07207603Cardiovascular Risk Factors (e.g., Hypertension)
University of Milano Bicocca
Observational
1,000
Milan
2024-06-17
Not yet open
European Institute of Oncology
Not applicable
120
Milan
2024-06-15
Recruiting
AbbVie
Phase 3
200
L’Aquila, Rozzano, Rome, Milan
2024-06-14
Active, closed
UCB Biopharma SRL
Phase 2/3
14
Bologna, Milan, Naples
2024-06-14
Recruiting
Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma
NCT06749600Primary Ovarian Leiomyosarcoma
Azienda USL Reggio Emilia - IRCCS
Observational
30
Modena, Parma, Reggio Emilia, Avellino, Catania, Milan, Monza, Naples
2024-06-14
Recruiting
Università Vita-Salute San Raffaele
Not applicable
210
Milan
2024-06-13
Recruiting
DEEP Substrate Mapping Versus Activation Mapping for VT
NCT06371729Ventricular Tachycardia
IRCCS Ospedale San Raffaele
Not applicable
222
Milan
2024-06-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Bari, Milan, Florence, Roma
2024-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Naples, Rome, Milan, Monza, Rozzano, Brescia, Genova, Novara
2024-06-10
Active, closed
Exelixis
Phase 2/3
600
Candiolo, Brescia, Catania, Milan, Naples, Rome, Rozzano, Verona
2024-06-07
Active, closed
GlaxoSmithKline
Phase 4
303
Brescia, Ferrara, Milan, Pisa, Reggio Emilia, Rome, Rozzano
2024-06-06
Active, closed
Amgen
Phase 3
563
Bari, Milan, Verona
2024-06-05
Recruiting
Immunocore Ltd
Phase 3
680
Bari, Bergamo, Meldola, Milan, Modena, Naples, Padova, Perugia
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Bari, Monserrato, Rome, Milan, Rozzano, Naples, Turin, Pontedera
2024-06-05
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Forlì, Milan
2024-06-03
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 2
25
Milan, Roma, Tricase
2024-06-03
Active, closed
Windtree Therapeutics
Phase 1/2
20
Alessandria, Brescia, Milan, Turin
2024-06-01
Recruiting
Buzzi Children's Hospital
Observational
3,000
Milan
2024-06-01
Recruiting
Prospective Registry of EoSinophilic esOphagitis
NCT06443346Eosinophilic Esophagitis
IRCCS San Raffaele
Observational
1,000
Milan
2024-06-01
Active, closed
Amgen
Phase 1/2
94
Milan, Pisa, Varese
2024-05-30
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Bari, Ferrara, Florence, Milan, Novara, Padova, Palermo, Perugia
2024-05-30
Active, closed
Stealth BioTherapeutics Inc.
Phase 3
313
Milan, Roma, Udine
2024-05-30
Active, closed
ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer
NCT06328738HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2 Positive Solid Tumors, HER2 Amplification
DrugsELVN-002·Eribulin·Leucovorin·Trastuzumab
Enliven Therapeutics
Phase 1
275
Catanzaro, Milan, Monza, Pisa, Reggio Emilia, Rome
2024-05-30
Active, closed
Amgen
Phase 1
120
Milan, Rozzano MI, Verona
2024-05-29
Recruiting
Harmony Biosciences Management, Inc.
Phase 3
134
Florence, Genova, Milan, Padova, Roma, Trieste
2024-05-28
Active, closed
Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach
NCT07420543Brain Tumors and/or Solid Tumors Including, Glioblastoma, Glioblastoma (GBM), Glioblastoma - Category
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
30
Milan
2024-05-27
Recruiting
University Hospital, Antwerp
Phase 3
174
Milan, Arezzo, Bergamo, Brescia, Florence, Lecco, Pavia, Pisa
2024-05-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Bergamo, Foggia, Milan, Novara, Palermo, Roma, Rome, Rozzano
2024-05-24
Recruiting
CDR-Life AG
Phase 1
42
Milan
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Naples, Ravenna, Aviano, Rome, Milan, Livorno, Padova
2024-05-24
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo
2024-05-23
Recruiting
Prognostic Recovery Observations and Guidance for Evaluating Stroke Survivors
NCT06465758Acute Stroke, Functional Recovery, Prognostic Factors
IRCCS San Raffaele
Observational
360
Milan
2024-05-21
Recruiting
Daiichi Sankyo
Phase 3
540
Bari, Bergamo, Brescia, Catania, Catanzaro, Genova, Milan, Monza
2024-05-21
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 3
122
Bari, Bologna, Brescia, Catania, Meldola, Milan, Novara, Palermo
2024-05-21
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Alessandria, Lecco, Milan, Monza, Naples, Pavia, Modena, Roma
2024-05-20
Active, closed
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms
DrugsTucatinib·Disitamab Vedotin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
54
Naples, Milan, Misterbianco (CT), Verona
2024-05-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Rome, Milan, Rozzano, Verona
2024-05-20
Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
NCT06400472Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung
DrugsSofe-M·Itraconazole·Bevacizumab·Carboplatin
Eli Lilly and Company
Phase 1
575
Milan
2024-05-20
Recruiting
NMD Pharma A/S
Phase 2
84
Bergamo, Bologna, Genova, Milan, Naples, Pisa, Roma
2024-05-16
Active, closed
Università Vita-Salute San Raffaele
Not applicable
400
Cagliari, Milan
2024-05-16
Active, closed
The OPBC-07/microNAC Study
NCT06529302Breast Cancer
University Hospital, Basel, Switzerland
Observational
2,000
Milan, Naples, Padova, Pavia, Roma
2024-05-15
Active, closed
Boehringer Ingelheim
Phase 2
190
Florence, Milan, Naples, Roma, Rozzano, Torrette Di Ancona
2024-05-15
Recruiting
Corheart 6 LVAS Study
NCT05876000Refractory Heart Failure
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
53
Milan, Torino
2024-05-14
Active, closed
INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC
NCT06295731Head and Neck Squamous Cell Carcinoma (HNSCC)
DrugsKeytruda·Pembrolizumab
Inhibrx Biosciences, Inc
Phase 2/3
410
Naples, Milan, Pavia
2024-05-14
Active, closed
Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)
NCT07461246Familial Adenomatous Polyposis (FAP), Attenuated Familial Adenomatous Polyposis (AFAP), MUTYH-Associated Polyposis (MAP), Non-APC/MUTYH Associated Polyposis (NAMP)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
1,500
Milan
2024-05-13
Recruiting
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
Not applicable
250
Bagno a Ripoli, Florence, Massa, Milan
2024-05-13
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-05-13
Recruiting
Hopital Foch
Phase 2
640
Milan, Livorno
2024-05-10
Active, closed
Sanofi
Phase 3
1,541
Milan, Rozzano, Rome, Bologna, Catania, L’Aquila, Pisa, Vicenza
2024-05-08
Recruiting
Centro Cardiologico Monzino
Observational
1,400
Milan
2024-05-07
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
56
Avellino, Alessandria, Biella, Milan, Novara, Pavia, Piacenza, Torino
2024-05-07
Recruiting
PSC Partners Seeking a Cure
Observational
2,000
Milan
2024-05-06
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Brescia, Catania, Florence, Foggia, Forlì, Milan, Modena, Monza
2024-05-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Naples, Rome, Milan, Pisa
2024-05-03
Active, closed
Hoffmann-La Roche
Phase 2
256
Tricase (LE), Rome, Milan, Pavia
2024-05-02
Active, closed
Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections
NCT06945627Severe Mental Illness, Inflammation, Viral Infections, Mood Disorders
Sara Poletti
Observational
408,551
Milan
2024-05-02
Recruiting
University of Milan
Phase 2/3
34
Milan
2024-05-01
Active, closed
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
1,000
Milan
2024-05-01
Recruiting
Enhanced Valves Interventions and Safe AI Generated End Results
NCT07213531Heart Valve Disease, TAVI, M-TEER, TTVI
Montreal Heart Institute
Observational
21,000
Brescia, Milan
2024-05-01
Recruiting
Cardiac Implantable Electronic Device- Induced Remodelling of Tricuspid Valve and Right Chambers
NCT06914570Cardiac Pacing, Artificial, Tricuspid Valve Regurgitation, Non-rheumatic
Istituto Auxologico Italiano
Observational
350
Milan
2024-05-01
By invitation
Travere Therapeutics, Inc.
Phase 3
100
Bari, Genova, Milan, Monza, Padova
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
10,000
Bologna, Ferrara, Genova, Milan, Palermo, Perugia, Pisa, Roma
2024-04-30
Recruiting
Francesco De Cobelli
Phase 2
33
Bergamo, Milan, Naples, Pisa
2024-04-30
Recruiting
AstraZeneca
Phase 3
582
Milan, Monza, Orbassano, Padova, Parma
2024-04-29
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
60
Milan, Rozzano, Verona
2024-04-29
Active, closed
Erasca, Inc.
Phase 3
78
Milan, Roma, Udine
2024-04-29
Recruiting
Eli Lilly and Company
Phase 3
510
Florence, Milan, Naples, Padova, Pisa, Rome, Vimercate
2024-04-29
Active, closed
Istituto Scientifico Italiano Colonna Vertebrale
Observational
9,651
Milan
2024-04-24
By invitation
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
52
Milan
2024-04-23
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
40
Milan
2024-04-23
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Milan, Orbassano, Torino, Bologna, Genova, Meldola, Novara, Pavia
2024-04-22
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Arezzo, Bergamo, Brescia, Milan, Roma, Rozzano, Torino
2024-04-18
Recruiting
Fondazione Italiana Linfomi - ETS
Observational
130
Alessandria, Ancona, Avellino, Aviano, Brescia, Castelfranco Veneto, Florence, Milan
2024-04-18
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Bologna, Milan, Naples, Pontedera Pisa, Rho, Roma, Rozzano, San Giovanni Rotondo
2024-04-17
Recruiting
Niguarda Hospital
Observational
20
Milan
2024-04-17
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Pozzilli, Milan, Rome, Florence, Bergamo, Cagliari, Catania, Chieti
2024-04-16
By invitation
Istituto Clinico Humanitas
Observational
100
Milan, Sassari
2024-04-15
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
300
Milan
2024-04-15
Recruiting
Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy
NCT06071507Gastric Outlet Obstruction, Pancreatic Cancer
IRCCS San Raffaele
Observational
250
Milan, Palermo
2024-04-15
Recruiting
European Institute of Oncology
Observational
234
Milan
2024-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Meldola, Aviano, Milan, Rozzano, Bologna, Genova, Roma
2024-04-14
Recruiting
AstraZeneca
Phase 3
675
Bergamo, Genoa, Milan, Monza, Padova, Pavia, Ravenna, Roma
2024-04-11
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Caserta, Florence, Genova, Grosseto, Monza, Milan, Piacenza, Gubbio
2024-04-11
Recruiting
Daiichi Sankyo
Phase 1/2
680
Candiolo, Milan, Naples, Rome, Rozzano
2024-04-10
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Rome, Milan, Florence, Parma
2024-04-10
By invitation
Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies
NCT07265908Gynecological Disorders, Male Infertility, Female Infertility, Pregnancy
IRCCS San Raffaele
Observational
3,000
Milan
2024-04-09
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Arezzo, Milan, Province of Macerata, Ravenna, Roma, Rozzano, Torino
2024-04-09
Recruiting
Permedica spa
Not applicable
50
Milan
2024-04-09
Recruiting
Psychological Assessment in Patients Treated with Spinal Cord Stimulation
NCT06761300Spinal Cord Stimulation (SCS), Chronic Pain
European Institute of Oncology
Observational
50
Milan
2024-04-09
Active, closed
Amgen
Phase 3
434
Reggio Emilia, Udine, Rome, Milan, Novara, Florence, Verona, Catania
2024-04-08
Recruiting
InnovHeart
Not applicable
30
Milan
2024-04-04
Active, closed
Novartis Pharmaceuticals
Phase 2
23
Milan, Naples
2024-04-04
Active, closed
TWi Biotechnology, Inc.
Phase 2/3
80
Milan, Modena, Rome
2024-04-04
Active, closed
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease
DrugPirfenidone
Avalyn Pharma Inc.
Phase 2
375
Torrette, Naples, Bologna, Venezia, Pavia, Milan, Rozzano, Catania
2024-04-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
780
Misterbianco, Meldola, Milan, Monza, Rome, Florence, Bergamo, Genova
2024-04-03
Recruiting
Hoffmann-La Roche
Phase 4
320
Meldola, Modena, Aviano (PN), Rome, Milan
2024-04-02
Recruiting
Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO
NCT06792643Cardiogenic Shock, Extracorporeal Membrane Oxygenation Complication, Platelet Dysfunction
DrugCangrelor
IRCCS San Raffaele
Phase 2
50
Milan
2024-04-01
Recruiting
Corbus Pharmaceuticals Inc.
Phase 1/2
348
Florence, Milan, Rome, Verona
2024-04-01
Active, closed
Takeda
Phase 2
213
Bologna, Milan, Palermo, Rome, Rozzano
2024-03-29
Active, closed
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
NCT06291376Immunoglobulin A Nephropathy, IgAN
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Phase 3
584
Agrigento, Bologna, Brescia, Cagliari, Florence, Milan, Padova, Parma
2024-03-29
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
150
Milan
2024-03-29
Active, closed
AstraZeneca
Phase 3
2,554
Bologna, Catanzaro, Chiavari, Desio, Milan, Naples, Parma, Rozzano
2024-03-29
Recruiting
Italian Sarcoma Group
Observational
250
Rozzano, Aviano, Orbassano, Bari, Bologna, Florence, Genova, Milan
2024-03-29
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Rome, Genoa, Milan, Naples
2024-03-28
Recruiting
Prehospital Resuscitation Intranasal Cooling Effectiveness Survival Study 2
NCT06025123Out-Of-Hospital Cardiac Arrest, Hypothermia, Ventricular Fibrillation
Karolinska Institutet
Not applicable
1,022
Milan
2024-03-27
Active, closed
Gilead Sciences
Phase 2
228
Bologna, Cagliari, Catanzaro, Milan, Negrar, Padova, Palermo, Roma
2024-03-27
Recruiting
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 1/2
180
Bologna, Milan, Monza
2024-03-26
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT06253871HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc
Phase 1
383
Florence, Milan, Naples
2024-03-25
Active, closed
Gilead Sciences
Phase 3
577
Brescia, Foggia, Milan, Monza, Pavia, Roma
2024-03-25
Recruiting
GlaxoSmithKline
Phase 3
864
Bolzano, Bologna, Milan, Naples, Pavia, Prato, Roma, Rozzano MI
2024-03-21
Recruiting
Verastem, Inc.
Phase 3
270
Aviano, Brescia, Catania, Milan, Naples, Padova, Roma, Rome
2024-03-18
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Bologna, Legnago, Milan, Padova, Roma
2024-03-15
By invitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
NCT05932615Aortic Valve Stenosis, Heart Valve Diseases, Aortic Valve Disease, Heart Disease Structural Disorder
Abbott Medical Devices
Not applicable
1,500
Milan
2024-03-15
Recruiting
Investigator Grant (IG) 2022 27746
NCT06341478Bladder Cancer
IRCCS San Raffaele
Not applicable
153
Milan
2024-03-15
Recruiting
AstraZeneca
Phase 3
100
Florence, Genova, Milan, Padova, Roma
2024-03-14
Recruiting
Janssen Research & Development, LLC
Phase 3
120
Alessandria, Bergamo, Bologna, Florence, Milan, Roma
2024-03-13
Recruiting
Eli Lilly and Company
Phase 3
90
Alessandria, Bergamo, Bologna, Florence, Milan, Roma
2024-03-13
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Bergamo, Foggia, Milan, Modena, Naples, Novara, Palermo, Roma
2024-03-13
Recruiting
IRCCS Ospedale San Raffaele
Observational
2,000
Milan
2024-03-13
Recruiting
IRCCS San Raffaele
Observational
500
Milan
2024-03-13
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Brescia, Cona, Genova, Milan, Rozzano, Pisa, Roma, Negrar
2024-03-12
Recruiting
The NEU-STIM Trial
NCT05942924Infant, Premature, Diseases, Birth, Preterm
Leiden University Medical Center
Not applicable
3,280
Milan
2024-03-11
Recruiting
Elixir Medical Corporation
Observational
5,000
Milan, Naples, Rome
2024-03-10
Recruiting
IRCCS San Raffaele
Observational
500
Milan
2024-03-07
Recruiting
University of Milan
Not applicable
400
Milan
2024-03-07
Recruiting
The Role of Attention in Modulating the Placebo Effect
NCT06827444Placebo Effect, Attention
Catholic University of the Sacred Heart
Not applicable
128
Milan
2024-03-07
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Ancona, Bergamo, Bologna, Brescia, Caserta, Cona, Pozzilli, Milan
2024-03-07
Recruiting
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Bayer
Phase 1
198
Milan, Naples
2024-03-07
Recruiting
European Institute of Oncology
Observational
60
Milan
2024-03-06
Recruiting
Takeda
Phase 2
268
Bologna, Milan, Palermo, Roma, Rome, Rozzano
2024-03-05
Active, closed
Eli Lilly and Company
Phase 3
17,300
Arzignano, Baggiovara, Bologna, Cinisello Balsamo, Ferrara, Florence, Genova, Milan
2024-03-05
Active, closed
Cynata Therapeutics Limited
Phase 2
60
Ancona, Milan, Roma, Rozzano, San Giovanni Rotondo, Venezia
2024-03-04
Active, closed
AstraZeneca
Phase 3
594
Florence, Milan, Naples, Padova, Pisa, Vicenza
2024-03-04
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Gussago, Milan, Pisa, Roma
2024-03-04
Active, closed
Byondis B.V.
Phase 1
17
Brescia, Candiolo, Milan, Ravenna
2024-03-04
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
96
Bologna, Caserta, Catania, Ferrara, Florence, Milan, Novara, Palermo
2024-03-01
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 2
46
Milan
2024-03-01
Recruiting
Niguarda Hospital
Observational
250
Milan
2024-03-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
150
Milan
2024-03-01
Recruiting
Novartis Pharmaceuticals
Phase 3
50
Ranica, Milan, Roma
2024-02-28
Recruiting
Terumo Europe N.V.
Not applicable
50
Milan, Rome, Turin
2024-02-27
Recruiting
Daiichi Sankyo
Phase 2/3
860
Aviano, Bologna, Catania, Florence, Milan, Monza, Naples, Roma
2024-02-27
Active, closed
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
NCT06239467Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
DrugsAtirmociclib·Tucatinib·Ribociclib·Fulvestrant
OnKure, Inc.
Phase 1
200
Milan, Monza, Rozzano
2024-02-26
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 4
84
Brescia, Lecco, Padova, Aviano, Torino, Milan
2024-02-26
Active, closed
Dianthus Therapeutics
Phase 2
65
Milan, Naples, Pisa, Rome
2024-02-23
Recruiting
Synnovation Therapeutics, Inc.
Phase 1
400
Milan
2024-02-23
Active, closed
AstraZeneca
Phase 2
142
Bari, Bologna, Milan, Naples, Palermo, Pavia, Peschiera del Garda
2024-02-22
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Meldola (Fc), Milan, Monza, Genova, Brescia, Roma, Ancona, Aviano (PN)
2024-02-21
Recruiting
AstraZeneca
Phase 3
5,250
Ancona, Florence, Genoa, Mestre, Milan, Naples, Pavia, Perugia
2024-02-21
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Aviano PN, Milan, Orbassano, Padova, Perugia, Pisa, Reggio Emilia, Rozzano MI
2024-02-20
Recruiting
Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.
NCT06099119Unresectable Pancreatic Cancer
Hospital Clinico Universitario de Santiago
Phase 4
100
Milan
2024-02-20
Active, closed
Vertex Pharmaceuticals Incorporated
Phase 1/2
47
Milan
2024-02-20
Active, closed
Gemelli Molise Hospital
Observational
372
Taranto, Naples, Milan, Campobasso
2024-02-20
Active, closed
AbbVie
Observational
1,200
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Rome, Turin, Palermo
2024-02-19
Recruiting
Italfarmaco
Phase 3
138
Lecco, Milan, Padova, Roma
2024-02-19
Recruiting
Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
NCT06306170Gynecologic Cancer, Radiotherapy Side Effect, Radiotherapy; Complications, Survivorship
IRCCS San Raffaele
Observational
1,000
Milan
2024-02-15
Recruiting
Nutrition Impact on PRGF Treatment for Tendinopathy
NCT06536582Shoulder Tendinopathy, Metabolic Alterations
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
52
Milan
2024-02-15
Recruiting
argenx
Observational
100
Milan
2024-02-13
Recruiting
University of Milano Bicocca
Phase 2
25
Milan
2024-02-12
Recruiting
IRCCS San Raffaele
Observational
2,000
Milan
2024-02-12
Recruiting
Pfizer
Phase 3
492
Milan, Legnano, Turin, Palermo, Ancona, Florence, Pisa, Bologna
2024-02-08
Recruiting
TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models
NCT06372054Oxidative Injury, Stress Physiological, Discogenic Pain, Cardiovascular Risk Factor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Observational
200
Milan
2024-02-05
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Bologna, Candiolo, Catania, Lecce, Meldola, Messina, Milan, Naples
2024-02-05
Recruiting
Deep Learning ECG Evaluation and Clinical Assessment for Competitive Sport Eligibility
NCT06285084Sports Cardiology, Preventive Cardiology, Electrocardiogram, Artificial Intelligence
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
531
Milan
2024-02-02
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
DrugAdagrasib
Mirati Therapeutics Inc.
Phase 2
200
Pesaro, Novara, Candiolo, Milan, Perugia, Roma
2024-02-01
Active, closed
Astellas Gene Therapies
Not applicable
119
Florence, Gussago, Messina, Milan, Pavia, Pisa, Roma, Udine
2024-02-01
Recruiting
INfectious DIsease REgistry BIObank
NCT06418048Bloodstream Infections, Central Nervous System Infections, Bone and Joint Infections, Endovascular Infections
IRCCS San Raffaele
Observational
10,000
Milan
2024-02-01
Recruiting
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
NCT07030569Radiomic, Radiomics, Breast Cancer Metastatic, Breast Cancer Stage IV
DrugTrastuzumab deruxtecan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
500
Milan
2024-02-01
Recruiting
The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
NCT06112639Sclerosis, Multiple, Neurocognitive Impairment, Mild, Neurocognitive Dysfunction
Fondazione Don Carlo Gnocchi ETS
Not applicable
192
Brescia, Messina, Milan
2024-01-31
Recruiting
Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06715046GVHD - Graft-Versus-Host Disease, Infections After HSCT, Transplant Associated Microangiopathy TAM, Sinusoidal Obstruction Syndrome (SOS)
University of Turin, Italy
Observational
30
Milan, Turin
2024-01-31
Recruiting
Dysphagia After Thyroidectomy
NCT06296420Goiter, Thyroid Disease
Istituto Auxologico Italiano
Observational
420
Milan
2024-01-31
Recruiting
The PRO-FUTURE Project
NCT06382233Ureteropelvic Junction Obstruction, Chronic Kidney Diseases
University of Campania Luigi Vanvitelli
Observational
85
Naples, Milan, Modena
2024-01-30
Active, closed
Incyte Corporation
Phase 3
617
Ancona, Catania, Milan, Pisa, Roma, Rozzano
2024-01-30
Recruiting
IRCCS San Raffaele
Observational
50
Milan
2024-01-29
Recruiting
European Institute of Oncology
Observational
104
Milan
2024-01-25
Active, closed
Sanofi
Phase 3
260
Torette, Genoa, Milan, Rozzano, Rome, Turin, Bergamo, Bologna
2024-01-23
Recruiting
Ascendis Pharma A/S
Phase 2
72
Milan
2024-01-23
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
DrugsAZD3470·Keytruda·Pembrolizumab
AstraZeneca
Phase 1/2
161
Alessandria, Bologna, Milan
2024-01-23
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
89
Milan, Padova, Ravenna, Rozzano, Udine
2024-01-22
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Alessandria, Bologna, Brindisi, Catania, Genova, Legnano, Milan, Pavia
2024-01-22
Recruiting
Cognitive Control During Sleep: the Strange Case of Self-Awakening
NCT06685380Self-awakening: Ability to Wake Up Without the Aid of Any Timekeeper
IRCCS San Raffaele
Observational
40
Milan
2024-01-22
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
100
Milan
2024-01-19
Active, closed
DualityBio Inc.
Phase 3
541
Bergamo, Brescia, Catania, Catanzaro, Milan, Pavia, Verona, Naples
2024-01-18
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
DrugsElironrasib·RMC-9805·Cetuximab·Pemetrexed
Revolution Medicines, Inc.
Phase 1/2
616
Meldola, Milan, Orbassano, Ravenna, Rome
2024-01-18
Active, closed
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
56
Milan
2024-01-16
Recruiting
IRCCS San Raffaele
Observational
70
Milan
2024-01-16
Recruiting
Astellas Pharma Global Development, Inc.
Phase 3
100
Milan, Padova, Torino
2024-01-16
Recruiting
University of Turin, Italy
Observational
10,500
Monza, Orbassano, Torino, Milan, Trento
2024-01-15
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
17
Milan
2024-01-15
Active, closed
Study of ALXN2220 Versus Placebo in Adults With ATTR-CM
NCT06183931Transthyretin Amyloid Cardiomyopathy
DrugCliramitug
Alexion Pharmaceuticals, Inc.
Phase 3
1,181
Bologna, Ferrara, Florence, Forlì, Messina, Milan, Naples, Padova
2024-01-11
Active, closed
AbbVie
Phase 2/3
89
Rozzano, Milan, Naples, Rome, Bologna, Palermo, Roma
2024-01-11
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Bologna, Florence, Milan, Novara, Padua, Pavia, Roma
2024-01-11
Recruiting
European Institute of Oncology
Observational
30
Milan
2024-01-11
Recruiting
Cognitive Screening in Lung Cancer Patients
NCT06727370Lung Disease, NSCLC (Non-small Cell Lung Cancer), SCLC
European Institute of Oncology
Observational
200
Milan
2024-01-10
Recruiting
Transforming Rehabilitation: Personalised Care for a Better Quality of Life
NCT06249958Osteoarthritis Secondary, Osteoarthritis Primary, Osteoarthritis, Knee, Osteoarthritis, Hip
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
2,000
Milan
2024-01-08
Recruiting
Daiichi Sankyo
Phase 3
50
Milan, Naples
2024-01-05
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 1/2
85
Milan
2024-01-04
Recruiting
Incyte Corporation
Phase 1
710
Milan, Rozzano, Verona
2024-01-04
Active, closed
BioMarin Pharmaceutical
Phase 1/2
18
Milan, Rome
2024-01-03
Active, closed
Novartis Pharmaceuticals
Phase 2
49
Genova, Milan, Roma, Naples
2024-01-03
By invitation
Sanofi
Phase 3
90
Milan, Padua, Rome, Naples, Pavia
2024-01-03
Recruiting
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
NCT06356727Heart Failure, Left Ventricular Dysfunction, Idiopathic Dilated Cardiomyopathy
Azienda Ospedaliera Universitaria Integrata Verona
Not applicable
190
Ferrara, Genova, Milan, Naples, Roma, Rome, Torino, Verona
2024-01-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
124
Florence, Milan, Padova, Pisa, San Giovanni Rotondo, Verona
2024-01-03
Active, closed
IRCCS San Raffaele
Observational
1,000
Milan
2024-01-01
Recruiting
Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
NCT07450612Colorectal Cancer, Adenoma Colon, Adenoma Colon Polyp, Colon Adenoma
San Raffaele University
Observational
1,200
Milan
2024-01-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Meldola, Milan
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
340
Cona, Meldola, Milan, Florence, Pisa, Castelfranco Veneto, Alessandria, Ancona
2023-12-31
Recruiting
Daiichi Sankyo
Phase 3
250
Bari, Bologna, Genova, Milan, Misterbianco, Naples, Padova, Prato
2023-12-30
Recruiting
Bristol-Myers Squibb
Phase 1/2
460
Bologna, Brescia, Milan, Pisa, Ravenna, Roma, Verona
2023-12-29
Recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Observational
15
Milan
2023-12-28
Recruiting
EXO Biologics S.A.
Phase 1/2
265
Florence, Genova, Milan, Modena, Padua
2023-12-28
Recruiting
Travere Therapeutics, Inc.
Phase 3
70
Bari, Genova, Milan, Monza, Padova
2023-12-28
Active, closed
Boston Scientific Corporation
Not applicable
484
Ancona, Milan, Cotignola, Roma
2023-12-28
Active, closed
Sanofi
Phase 3
943
Augusta, Cona, Florence, Genoa, Milan, Naples, Cefalù, Rome
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Bari, Bologna, Catania, Milan, Naples, Padova, Roma, Rome
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 3
190
Aviano, Milan, Monza, Naples, Rome
2023-12-21
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
44
Meldola, Milan, Perugia
2023-12-20
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Naples, Rome, Brescia, Milan, Rozzano, Turin, Monserrato, Pisa
2023-12-20
Recruiting
Janssen Research & Development, LLC
Phase 1
300
Bologna, Milan
2023-12-20
Active, closed
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
NCT06046222Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
NS Pharma, Inc.
Phase 2
45
Milan, Roma, Trento, Verona
2023-12-20
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Aviano, Brescia, Cona, Genova, Lecce, Meldola, Milan, Padova
2023-12-20
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Ancona, Candiolo, Meldola, Milan, Naples, Parma, Pisa, Rozzano
2023-12-20
Recruiting
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
NCT05955365Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor
DrugsDOAC·Aspirin
Insel Gruppe AG, University Hospital Bern
Phase 4
3,010
Catania, Milan
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Meldola, Milan, Catania, Foggia, Terni
2023-12-18
Recruiting
Janssen-Cilag Ltd.
Observational
900
Bologna, Bolzano, Brindisi, Florence, Lecce, Milan, Naples, Palermo
2023-12-18
Active, closed
REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)
NCT05973773Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
DrugZipalertinib
Taiho Oncology, Inc.
Phase 3
285
Meldola, Genova, Milan, Modena, Pavia, Ravenna, Roma, Verona
2023-12-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Bari, Meldola, Udine, Milan, Bergamo, Catanzaro, Florence, Roma
2023-12-15
Recruiting
Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
NCT06154785Colorectal Surgery, Benign or Malignant Rectal or Colon Tumors
Bordeaux Colorectal Institute Academy
Observational
300
Milan
2023-12-15
Recruiting
AstraZeneca
Phase 3
1,145
Aviano, Florence, Milan, Modena, Naples, Padova, Pavia, Rozzano
2023-12-14
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Naples, Palermo, Bologna, Milan, Padova, Roma, Rozzano
2023-12-13
Active, closed
Sanofi
Phase 3
1,655
Cona, Florence, Genoa, Milan, Monza, Naples, Rome, Orbassano
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Meldola, Monza, Turin, Milan, Modena, Naples, Novara, Pavia
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Meldola, Tricase, Genoa, Candiolo, Ascoli Piceno, Bologna, Brescia, Milan
2023-12-12
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Foggia, Milan, Monza, Torino, Padova, Siena, Catania, Florence
2023-12-11
Active, closed
Sanofi
Phase 2
197
Torette, Florence, Milan, Naples, Rome, Novara, Varese, Verona
2023-12-11
Active, closed
Orchard Therapeutics
Phase 3
41
Milan
2023-12-11
Recruiting
Omikron Italia S.r.l.
Phase 3
1,000
Milan
2023-12-11
Recruiting
Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery
NCT06281210Breast Cancer, Triple Negative Breast Cancer, HER2-positive Breast Cancer, Neoadjuvant Chemotherapy
European Institute of Oncology
Not applicable
77
Candiolo, Milan
2023-12-11
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Ancona, Milan, Rozzano
2023-12-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Bologna, Aviano, Rome, Milan, Rozzano, Candiolo, Bari, Brescia
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Bari, Aviano, Udine, Milan, Naples, Perugia, Catania, Cuneo
2023-12-06
Active, closed
Aura Biosciences
Phase 3
108
Florence, Milan, Roma
2023-12-06
Recruiting
Anterior Cruciate Ligament Study
NCT06194682ACL Injury, ACL, Anterior Cruciate Ligament Rupture
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Observational
370
Milan
2023-12-06
Active, closed
Gilead Sciences
Phase 2
176
Catanzaro, Milan, Roma, Rozzano
2023-12-05
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
257
Castellana Grotte, Catania, Florence, Genova, Milan, Modena, Naples, Pisa
2023-12-05
Recruiting
IRCCS San Raffaele
Phase 2
167
Milan
2023-12-04
Active, closed
AstraZeneca
Phase 3
760
Florence, Milan, Padova, Pisa, Rozzano, Tricase, Lecce
2023-12-04
Active, closed
AnaptysBio, Inc.
Phase 2
132
Bologna, Cagliari, Catania, Legnano, Milan, Pavia, Rozzano, San Donato
2023-12-04
Recruiting
Incyte Biosciences Italy S.r.l
Observational
200
Milan
2023-12-04
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
100
Bologna, Careggi, Rozzano, Milan, Padova, Palermo, Prato, Roma
2023-12-01
Recruiting
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Not applicable
1,000
Milan
2023-12-01
Recruiting
EffectiVenEss of a Rehabilitation Treatment With Nordic Walking in obEse or oveRweight Patients
NCT05987410Cardiovascular Diseases, Diabete Type 2, Overweight and Obesity
Fondazione Don Carlo Gnocchi ETS
Not applicable
105
Milan
2023-12-01
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
San Giovanni Rotondo, Rozzano, Torino, Bologna, Foggia, Messina, Milan, Modena
2023-12-01
Recruiting
Sanofi
Observational
230
Bologna, Brescia, Florence, Milan, Naples, Roma, Verona
2023-11-30
Recruiting
Octapharma
Phase 4
28
Catanzaro, Florence, Milan
2023-11-28
Active, closed
424 General Military Hospital
Observational
122
Milan, Roma, Siena, Udine
2023-11-28
Active, closed
Incyte Corporation
Phase 3
450
Brescia, Catania, Milan, Rome, Rozzano
2023-11-27
Recruiting
BioMarin Pharmaceutical
Observational
400
Genoa, Roma, Milan, Rome
2023-11-27
Recruiting
Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
NCT06001645Acute Respiratory Distress Syndrome, Barotrauma
Università Vita-Salute San Raffaele
Observational
110
Cagliari, Milan, Pisa, Potenza
2023-11-27
Recruiting
424 General Military Hospital
Observational
150
Milan, Roma, Siena, Udine
2023-11-25
Rows per page Showing 1001–1500 of 2846
Previous 1 2 3 4 5 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,846 of those studies with a site in Milan.

How many clinical trials are recruiting in Milan?

1,595 of the 2,846 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 145 have not yet opened recruitment, 1,033 are active but closed to new participants, and 73 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.